Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Global Automation in Biopharma Industry Markets, Trends, Opportunity, & Forecast 2018-2028: Significant Spending by Biopharma Companies, Research Institutions Drives Market Growth | ||
| By: PR Newswire Association LLC. - 28 Feb 2024 | Back to overview list |
|
|
DUBLIN, Feb. 27, 2024 /PRNewswire/ -- The "Automation in Biopharma Industry Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ResearchAndMarkets.com's offering.  The Global Automation in Biopharma Industry Market was valued at USD 1775.20 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.80% through 2028, reaching USD 2468.19 million. Lab automation systems enable high-throughput screening of compounds, allowing researchers to quickly test many potential drug candidates. This is essential in the early stages of drug discovery. Automation systems in the lab provide precise and accurate handling of samples, reducing the risk of human error and ensuring consistent and reliable results. Automation simplifies data collection, storage, and analysis. It enables real-time monitoring and data processing, facilitating faster decision-making in research and development. Automated processes are more efficient and can run continuously, reducing the time and effort required for experiments and assays. This accelerates research and development timelines. Automation reduces the need for manual labor in repetitive and time-consuming tasks, resulting in cost savings and the redeployment of human resources to more strategic activities. Automation optimizes the use of resources, such as reagents, consumables, and equipment, making laboratory operations more cost-effective. In biopharmaceutical manufacturing, process automation is crucial. It involves the use of automated systems and instruments for tasks such as cell culture, fermentation, purification, and fill-finish operations. Process automation ensures the precise control of critical parameters (e.g., temperature, pH, and agitation) to maintain product quality and consistency. Robotic systems are employed for a wide range of tasks, from drug discovery and sample handling to filling and packaging in manufacturing. Robots can be programmed to handle samples, reagents, and labware, performing tasks with precision and repeatability. Ongoing technological innovations in automation, such as the use of artificial intelligence, machine learning, and robotics, are driving the adoption of cutting-edge systems for research and production. Biopharmaceutical products are becoming more complex, requiring advanced automation to produce biologics, cell therapies, and gene therapies. The North America region dominates the Global Automation in Biopharma Industry Market in 2022. North America, particularly the United States, is home to a significant number of leading biopharmaceutical companies, research institutions, and academic centers. These organizations invest heavily in automation to improve their research, development, and manufacturing processes. The region has a well-developed technological infrastructure and a strong industrial base, making it easier for companies to adopt and integrate automation solutions. Competitive Landscape
Report Scope
Automation in Biopharma Industry Market, By Application:
Automation in Biopharma Industry Market, By Component:
Automation in Biopharma Industry Market, By region:
For more information about this report visit https://www.researchandmarkets.com/r/51d6ei About ResearchAndMarkets.com
Research and Markets Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg SOURCE Research and Markets 
|
||
|
|
||
 | Back to overview list | |
View original content: